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Abstract
Background: Despite conflicting results on the use of hormone replacement therapy (HRT) there is no doubt that 
many women benefit from it. Women using HRT are known to be more health conscious in general with putative 
positive implications in the mouth. However, we observed recently in our cohort hardly any difference in oral health 
status between HRT-users and non-users. There are only a few studies about HRT and oral microbiota. We hypothesized 
that counts of periodontal micro-organisms are lower in health-conscious HRT-users than non-users.
Methods: Two-year open follow-up study was conducted on originally 200 HRT-users and 200 non-users from age 
cohorts of 50-58 years. After clinical examination pooled subgingival plaque samples were taken for polymerase chain 
reaction analyses. The results of finally 135 women meeting the inclusion criteria were analyzed with cross-tabulation 
and chi-square test. Explanatory factors were studied by step-wise logistic regression analysis.
Results: In HRT group, the numbers of positive samples for Porphyromonas gingivalis (P. gingivalis, p < 0.07), Prevotella 
intermedia (P. intermedia, p < 0.05)and Tannerella forsythia (T. forsythia, p < 0.01) decreased in women with ≥ 4-mm-deep 
pockets. Respectively in HRT users with ≥ 6-mm-deep pockets the numbers of positive samples for P. gingivalis (p < 
0.05) and T. forsythia (p < 0.01) were decreased. No corresponding differences were observed in the non-HRT group. In 
logistic regression, the existence of deep periodontal pockets explained the majority of cases harboring specific micro-
organisms in both groups.
Conclusion: Although use of HRT did not correlate with periodontal health status, HRT led to decreasing numbers of 
positive samples of the periodontal pathogens P. gingivalis and T. forsythia. Further studies with longer observation time 
are needed to observe the clinical relevance of the results.
Background
Women use hormone replacement therapy (HRT) to
cope with estrogen deficiency-induced vasomotor and
urogenital symptoms. Women do not only take HRT to
avoid climacteric symptoms but also to maintain quality
of life and to prevent osteoporosis [1,2]. The use of HRT
has received much publicity, however, when the results
from large randomized controlled trials were published
[3-6]. Recent experimental and clinical studies have indi-
cated that effects of HRT depend on the estrogen and
progesterone/progestin formulation, dosage, mode of
administration, patient's age, associated diseases, and
duration of treatment [7,8]. However, there is no doubt
that many women clearly benefit from the use of HRT,
which may also have implications in the oral cavity [9].
Chronic infections are involved in the etiopathogenesis
of many systemic diseases by releasing pro-inflammatory
mediators that may cause endothelial damage and initi-
ate, for example, cholesterol plaque attachment (for
review, see [10]). Periodontal disease being highly preva-
lent in the populations presents a marked inflammatory
burden in this regard (for review, see [11]).* Correspondence: laura.tarkkila@helsinki.fi
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odontal microbiota among peri-menopausal and post-
menopausal women [12]. However, sex hormones have
long been considered to play an influential role on peri-
odontal tissues and periodontal disease progression and
therefore the role of sex hormones has been of interest in
further investigations [13-16]. We thought it interesting
to study if differences occur in harboring certain peri-
odontal bacteria, namely Porphyromonas gingivalis (P.
gingivalis), Tannerella forsythia (T. forsythia), Aggregati-
bacter actinomycetemcomitans (A. actinomycetemcomi-
tans), Treponema denticola (T. denticola), Prevotella
intermedia (P. intermedia) and Prevotella nigrescens (P.
nigrescens), between pre- and postmenopausal women
using or not using HRT. The follow-up time was two
years and the present report is a continuation of our
study on oral health of the cohort of peri-menopausal and
postmenopausal women in the age groups of 50-58 years
[17]. In the earlier study we did not observe any differ-
ence in the clinical oral health status between the groups.
However, taking into account the known associations
between periodontal bacteria and systemic diseases [10]
and the interactions between HRT use and general health
[6] we thought that HRT might affect periodontal infec-
tions as reflected in the occurrence of specific bacteria.
We thus assumed that the more health-conscious HRT
users harbor less frequently periodontal pathogens when
compared with non-users at the end of this 2-year study.
Methods
Patients and their examination
Details of our patient material are given in our earlier
contribution [17]. Patients were chosen from original
sample of 3173 women at age cohorts 50, 52, 54, 56, and
58 years, who had participated in our questionnaire study
on oral symptoms [18]. Of those five age cohorts 40
women reporting the use of HRT and 40 reporting not to
use HRT at the time of the questionnaire were randomly
selected and invited to attend our clinical study. Hence,
200 HRT users and 200 non-HRT users received our invi-
tation letter. One recall letter was sent to those who did
not respond to the first invitation.
For the baseline study altogether 249 women attended,
with a response rate of 62%. After two years all those who
attended the baseline clinical study were invited to a fol-
low-up study. For the follow-up study 193 women
attended (78%). However, for statistical analyses of this
follow-up study the women who had changed their HRT
protocol (using/not-using HRT) between the baseline
and 2-year follow-up were excluded (n = 32). Also women
who had reported regular menstruation were excluded
from the final analyses (n = 11). Finally the results from
161 were included in our analyses but complete microbi-
ological results were available for only 135 subjects. The
study profile is given in Figure 1.
Ethical approval of the study had been originally given
by the City of Helsinki Health Department (ethical per-
mit #53 1.4.1997). All subjects attending signed an
informed consent according to the Declaration of Hel-
sinki.
Use and duration of prescribed medications including
HRT as well as illnesses diagnosed by physician were
asked with open questions with a structured question-
naire. Use of intrauterine contraception was not consid-
ered as HRT. For the statistical analyses a woman was
included into the HRT group if she had used HRT at least
six months at the time of the questionnaire.
Both the periodontal examinations and microbiological
samplings, at baseline and two years later, were made by
one dentist (author L.T). Oral examinations were made
according to the WHO guidelines [19,20]. Panoramic jaw
radiographs were available of each subject at the clinical
examination. Periodontal probing depths were deter-
mined at all mesial, distal, vestibular (buccal, labial), and
oral (lingual, palatal) tooth surfaces for scoring the Com-
munity Periodontal Index of Treatment Needs (CPITN)
[19]. The periodontal pocket depths were measured with
a WHO probe (tip diameter 0.5 mm) to the nearest milli-
Figure 1 Flow-chart of the inclusion of subjects.
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the pocket. "Periodontitis" was diagnosed if at least one
sextant had a CPITN - score 3 or higher, thus indicating
at least ≥ 4 mm deep pockets in the subject. Individual
pocket depths were not recorded separately. However, the
number of ≥ 6 mm deep pockets was counted separately
for each patient.
Microbial sampling methods and analyses
Subgingival plaque from the four deepest periodontal
sites was sampled in every patient. If no ≥ 4 mm pockets
existed or there were less than four ≥ 4 mm pockets in the
subject the rest of the plaque samples were taken from
the first premolars. Before sampling the supragingival
sites, plaque was gently removed with a cotton swab and
the site of collection was isolated with cotton rolls and
dried. Thereafter, the subgingival plaque samples were
taken with a sterile curette and placed into a micro-cen-
trifuge tube containing 0.5 ml distilled water. The pooled
samples were then centrifuged and 5 μl aliquots of super-
natant were added to the PCR reaction mixtures. The
PCR method has been described in detail by Wahlfors et
al. [21] and Meurman et al. [22]. Periodontal bacteria A.
actinomycetemcomitans, P. gingivalis, T. forsythia, T. den-
ticola, P. intermedia and P. nigrescens were analyzed.
Statistical methods
Women using or not using HRT were analyzed separately
and then the groups were compared in the 2-year follow-
up scheme. Only those who were examined both at base-
line and then followed-up for two years were included in
the final analyses. Cross-tabulations and chi-square tests
were used in the SPSS for Windows statistical program
(SPSS Inc. Chicago, Ill., USA, version 13.0). Stepwise
logistic regression analyses were made to study the
explanatory factors for the positive periodontal microbial
findings. The explanatory factors used in the backward
stepwise logistic regression model were age, prevalence of
cardiovascular disease, number of teeth, use of HRT,
WHO diseased, missed, filled tooth index - score, exis-
tence of ≥ 4 mm deep and ≥ 6 mm deep periodontal
pockets using the CPITN-score data, and self-assessed
poor oral health. The effect of systemic diseases and
medications on the results was analyzed separately for
HRT and non-HRT groups using median values of the
total number of concomitant illnesses and drugs used
daily; both at baseline and two years later.
Results
The reasons for drop-outs and exclusion from the study
were mainly change in the original protocol by either
starting HRT by women originally assigned to the non-
HRT group or vice versa, or lack of interest. The demo-
graphic characteristics of the drop-outs and those
excluded did not differ from the women who were eligible
for the 2-year follow-up analyses. As expected, women
not using HRT reported more often climacteric symp-
toms than HRT users: 35% at baseline vs. 13% at the 2-
year examination, respectively (p < 0.001).
At baseline the percentage of women with periodontitis
(defined as at least one sextant with CPITN score-3) was
79% in HRT group and 80% in non-HRT group. Two
years later the respective figures were 71% and 76%. The
mean numbers of ≥ 6 mm deep periodontal pockets were
0.9 ± 1.7 at baseline vs. 1.1 ± 2.1 two years later in the
HRT group, and 1.0 ± 1.7 vs. 1.2 ± 1.9, respectively, in the
non-HRT group. These differences were not statistically
significant. More detailed data of the dental health
parameters are described in Table 1.
Figure 2 gives the frequencies of the positive periodon-
tal microbial results of the subjects with ≥ 4 mm and ≥ 6
mm deep periodontal pockets, respectively, as assessed
using the CPITN scoring. In general, at baseline the peri-
odontal pathogen P. gingivalis was detected in approxi-
mately 20% among all the women, while A.
actinomycetemcomitans was detected in less than 5%. T.
forsythia and T. denticola were detected in 30-50% of the
women. There was no statistically significant difference
in the frequency of positive microbial findings between
the groups at baseline. However, two years later signifi-
cantly less positive cases of P. intermedia (p < 0.05) and T.
forsythia (P < 0.01) were detected in the samples from the
≥ 4 mm deep pockets of the HRT users while no such dif-
ference was observed in the non-HRT group. Of the HRT
users the decrease in the number of positive samples of P.
gingivalis almost reached statistical significance in the ≥ 4
mm deep pockets (P = 0.069). Correspondingly, the 2-
year follow-up results of the samples from the ≥ 6 mm
deep pockets of the women using HRT showed a signifi-
cant decrease in the number of positive cases of P. gingi-
valis (p < 0.05) and T. forsythia (p < 0.05) while no
difference was observed in the non-HRT group.
When the background variables for the prevalence of
periodontal micro-organisms in general were analyzed in
the stepwise logistic regression, the existence of deep
periodontal pockets (data based on CPITN score 3 or
higher) explained the majority of the cases. As regards
the effect of reported systemic diseases on the microbio-
logical results, A. actinomycetemcomitans was found to
be more prevalent in women with cardiovascular disease
(Odds ratio [OR 5.48], 95% confidence interval [CI] 1.04 -
29.77; p < 0.05). No other bacterial species investigated
associated statistically with any systemic disease
reported. However, in general the number of these cases
was only a few individuals, so the finding on A. actinomy-
cetemcomitans probably has no clinical relevance.
Similarly to the results of the prevalence of reported
systemic diseases vs. positive bacterial samples analyses
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Table 1: Descriptive data of the study subjects divided in groups according to the use of hormone replacement therapy 
(HRT).
Baseline Two-year follow-up
HRT (106) Non-HRT (55) Significance
between 
groups
HRT (106) Non-HRT (55) Significance 
between 
groups
Mean age 55.4 ± 2.7 55.9 ± 2.4 ns. 57.4 ± 2.7 57.9 ± 2.4 ns.
Current smoker 23(22%) 11(20%) ns. 19(18%) 8 (15%) ns.
Current climateric 
symptoms
16 (15%) 24 (44%) p < 0.001 14 (13%) 19 (35%) p < 0.001
Satisfactory 
self-assesed dental 
health
65 (61%) 28 (51%) ns. 63 (59%) 31 (56%) ns.
Diagnosed illness:
Cardiovascular 
disease
19 (18%) 10 (18%) ns. 25 (24%) 11 (20%) ns.
Psychiatric disease 1 (1%) 2 (4%) ns. 1 (1%) 3 (6%) ns.
Asthma 8 (8%) 3 (6%) ns. 12 (11%) 3 (6%) ns.
Rheumatic disease 8 (8%) 2 (4%) ns. 6 (6%) 3 (6%) ns.
Regular 
medication:
Use of 
cardiovascular 
drugs#
29 (27%) 14 (26%) ns. 39 (37%) 14 (26%) ns.
Use of neurological 
drugs#
7 (7%) 10 (18%) p < 0.05 5 (5%) 9 (16%) p < 0.05
Use of respiratory 
drugs#
7 (7%) 4 (7%) ns. 15 (14%) 4 (7%) ns.
Use of analgesics 
and antipyretics
7 (7%) 1 (2%) ns. 5 (5%) 5 (9%) ns.
Allergy medication 4 (4%) 0 (0%) ns. 0 0 -
Oestrogen therapy 49 (47%) 47 (47%)
Progestin therapy 2 (2%) 1 (1%)
Combination 
therapy
53 (51%) 53 (53%)
Ns. = Statistical difference non-significant.
#Includes diuretics, antihypertensive agents, nitrates, digitalis and antiarrhythmic agents;
##Includes antidepressant drugs, tranquilizers, sedatives and antipsychotic agents;
### Mainly medication for asthma.
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microbiological results showed that in addition to hor-
mones in the HRT group other medication was rare in
the subjects. At baseline the mean number of daily used
drugs was 0.7 in all the women while two years later the
respective figures were 0.5 drugs in the HRT group and
0.7 drugs in the non-HRT group. At the 2-year examina-
tion, women of the non-HRT group reported more often
use of neurological drugs than those of the HRT group
(16% vs. 5% p < 0.01). In the non-HRT group T. forsythia
was detected more often among women not using any
systemic drugs (73.7% vs. 26.3%, p < 0.05). Again, how-
ever, the number of the women in these subgroups ana-
lyzed was small and, subsequently, the findings may not
have clinical relevance.
In both groups the main explanatory factor in the
model for the occurrence of P. gingivalis, P. intermedia, T.
forsythia and T. denticola was the existence of deep peri-
odontal pockets. The results of the stepwise logistic
regression analyses are given in detail in Table 2.
Discussion
We observed that the number of T. forsythia- positive
samples decreased significantly during the 2-year follow-
up in both study groups while the decrease in the number
of P. gingivalis - positive samples was significant only in
the HRT users, in particular in women with ≥ 6 mm deep
periodontal pockets. A significant decrease was also
observed in the P. intermedia-positive samples from
women of the HRT group with ≥ 4 mm deep periodontal
pockets. No such differences were observed in the non-
HRT group. These findings partly support our study
hypothesis, namely that HRT use may affect periodontal
infections, since a decrease was observed specifically in
the number of positive samples for the pathogens T. for-
sythia and P. gingivalis.
Because our follow-up time was only two years no sig-
nificant difference was expected in the clinical periodon-
tal status between the women using or not using HRT. As
earlier reported this was indeed the case in the present
study cohort [17]. The strongest explanatory factor for
harboring the bacteria investigated was the existence of
deep periodontal pockets in both study groups. This
result came as no surprise since periodontal pockets and
furcation lesions are obviously the characteristic sites
harboring periodontal pathogens. Similarly, self-assessed
poor oral health status associated with harboring the bac-
teria investigated but in the present study only the less
harmful P. nigrescens - species linked statistically with this
parameter. P. nigrescens has been associated with gingivi-
tis [23], but it is also frequently isolated from periodon-
tally healthy sites similar to the P. intermedia species [24].
Since we used pooled plaque samples there are no data
from individual periodontal pockets. Our aim was rather
to assess the overall effect of HRT on periodontal micro-
biota than monitoring single pockets in this respect. In
the retrospect, it might have been interesting to monitor
the periodontal bacteria at individual pockets. Taken
together, however, more long-term investigations are
needed for confirming the present results and for the
final evaluation of the effect of HRT on periodontal
micro-organisms.
It is worth a notion that oral micro-organisms have
been shown to metabolize in vitro steroid hormones
[25,26]. The metabolism of progesterone, for example,
has been shown to increase in inflamed gingival tissue
[27]. Of the bacterial species analyzed in our study, T.
denticola has been shown to utilize host-derived steroids
as growth factors which phenomenon may link to its vir-
ulence [28]. Hence, in light of these metabolic findings
one might have expected increased T. denticola counts
during the 2-year observation which is contrary to our
Figure 2 Periodontal micro-organisms detected at baseline and 
two years later in the women with (HRT) or without (non-HRT) 
hormone replacement therapy. Graph A shows the results of wom-
en with the Community Periodontal Index for Treatment Need (CPITN) 
score 3, indicating the existence of ≥ 4 mm deep periodontal pockets, 
and graph B of those with CPITN score 4, respectively, indicating ≥ 6 
mm periodontal pockets. A.a. = Aggregatibacter actinomycetemcom-
itans, P.g. = Porphyromonas gingivalis, P.i. = Prevotella intermedia, P.n. 
= Prevotella nigrescens, T.f. = Tannerella forsythia, T.d. = Treponema 
denticola. The asterisks show statistically significant differences be-
tween baseline and follow-up samples (*p < 0.05, **p < 0.01; #p = 0.07).
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of the interactions between steroid hormones, periodon-
tal tissue and micro-organisms. There is a need for more
in-depth studies also in this area.
Earlier investigations have shown that in menopause
the risk for tooth loss is smaller in women using HRT
[29]. The circulating levels of estrogen influence alveolar
bone density so that more periodontal lesion sites showed
loss in alveolar bone density if serum estradiol level was
suboptimal [30]. In our study the women using HRT had
used it at least for 6 months already in the beginning of
the investigation so they were in the steady state regard-
ing hormone balance. However, Pilgram et al. [31] inves-
tigated 135 women in a randomized controlled trial with
estrogen replacement for three years and did not find sta-
tistically significant changes in clinical attachment of
teeth and bone mineral density of lumbar spine. A study
from Spain, on the other hand, showed improvement in
periodontal probing depths and tooth mobility in 190
women randomized to receive HRT for one year [32].
However, there are no systematic studies on the effect of
different hormone combinations on periodontal micro-
organisms and oral health parameters. It can be assumed
that different hormone combinations may also affect
periodontal tissues and microbiota in a highly specific
way.
To our knowledge, the present study was the first fol-
low-up study where periodontal micro-organisms in gen-
eral have been investigated in clearly defined age groups
of peri-menopausal and postmenopausal women. Nor-
deryd and coworkers reported earlier that postmeno-
pausal women taking estrogen supplementation had
more frequent gingival bleeding than control group, but
they did not find significant differences in the levels of
periodontal pathogens examined except for Capnocy-
tophaga -species which are usually implicated in the initi-
ation of puberty gingivitis [12,14,33]. The strength of the
present study was the fact that the subjects were origi-
nally recruited from a large group of women invited for
free mammography examination in age groups of 50-58
years [17,18]. Since the examination was free-of-charge it
can be anticipated that selection bias was minimal. How-
ever, there is always the possibility that women less inter-
ested in their health did not come, but the same holds
true for both those using and not using HRT. The weak-
ness of the study was the fairly short 2-year follow-up
period. Hence big changes in oral health parameters were
not to be expected. For practical reasons the protocol had
to be time-restricted and a 2-year longitudinal study was
Table 2: Odds ratios (OR) with 95% confidence intervals (95% CI) of the statistically significant explanatory factors after 
backward elimination for the prevalence of periodontal micro-organisms analyzed by stepwise logistic regression.
Bacterium# Explanatory factor§ OR 95% CI Significance
Baseline
P.g. Periodontal pockets 3.73 1.74-8.00 p = 0.001
P.i. Periodontal pockets 2.77 1.57-4.91 p < 0.001
P.n. Poor oral health 0.40 0.19-0.82 p = 0.012
T.f. Periodontal pockets 4.44 2.44-8.07 p < 0.001
T.d. Periodontal pockets 2.26 1.28-3.97 p = 0.005
2 year-Follow-up
A.a. HRT§§ 0.21 0.48-0.93 p = 0.040
Cardiovascular
medication§§§ 5.48 1.04-28.77 p = 0.044
P.g. Periodontal pockets 3.04 1.11-8.34 p = 0.031
P.i. Periodontal pockets 1.98 1.09-3.59 p = 0.025
P.n. Number of teeth 1.08 1.00-1.16 p = 0.045
T.d. Periodontal pockets 2.95 1.06-8.19 p = 0.038
#A.a. = Aggregatibacter actinomycetemcomitans; P.g. = Porphyromonas gingivalis;
P.i. = Prevotella intermedia; P.n. = Prevotella nigrescens; T.f. = Tannerella forsythia; T.d. = Treponema denticola.
§Periodontal pockets: >4 mm deep pockets; Poor oral health = self-assessed poor oral health;
§§HRT = hormone replacement therapy
§§§Includes diuretics, antihypertensive agents, nitrates, digitalis and antiarrhythmic agents
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Another weakness was the drop-out of subjects which
was mainly due to the reason that women originally not
using HRT had started the therapy and those in the HRT
group had ceased using hormones during the 2-years of
follow-up. They were then excluded from the statistical
analyses.
Finally, the observation that certain periodontal patho-
gens decreased in the HRT group during the 2-year fol-
low-up might also be due to increased health
consciousness of the participants. The women might
have improved their oral hygiene habits after oral hygiene
information given at the baseline clinical examination.
Thus an unavoidable bias caused by trial effect might
modify the results in this respect.
Conclusion
To conclude, we observed a decreased number of P. gingi-
valis- and T. forsythia- positive samples in women of the
HRT group during the 2-year follow-up. The findings
partly support our study hypothesis, namely that HRT
use may affect periodontal infections. Clinical relevance
of the results needs to be assessed in future studies with
longer observation time, however.
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